Inventor
WENDER PAUL A
US28 patents
⚠️ This page may combine multiple inventors who share the name “WENDER PAUL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
12 patentsUS6495663B1Dec 17, 2002
Method and composition for enhancing transport across biological membranes
UNIV LELAND STANFORD JUNIOR268 citations99
US6306993B1Oct 23, 2001
Method and composition for enhancing transport across biological membranes
UNIV LELAND STANFORD JUNIOR361 citations99
US7585834B2Sep 8, 2009
Transporters comprising spaced arginine moieties
UNIV LELAND STANFORD JUNIOR67 citations94
US7256286B2Aug 14, 2007
Bryostatin analogues, synthetic methods and uses
UNIV LELAND STANFORD JUNIOR29 citations89
US6624189B2Sep 23, 2003
Byrostatin analogues, synthetic methods and uses
UNIV LELAND STANFORD JUNIOR48 citations89
US8735609B2May 27, 2014
Bryostatin analogues, synthetic methods and uses
UNIV LELAND STANFORD JUNIOR5 citations73
US7232842B2Jun 19, 2007
Kinase inhibitors and associated pharmaceutical compositions and methods of use
UNIV LELAND STANFORD JUNIOR9 citations73
US10654875B2May 19, 2020
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
UNIV LELAND STANFORD JUNIOR2 citations70
US7151116B2Dec 19, 2006
Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
UNIV LELAND STANFORD JUNIOR9 citations68
US7067698B2Jun 27, 2006
Bi-directional synthesis of oligoguanidine transport agents
UNIV LELAND STANFORD JUNIOR4 citations60
US10961263B2Mar 30, 2021
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
UNIV LELAND STANFORD JUNIOR0 citations59
US11370743B2Jun 28, 2022
Prodrug derivatives of protein kinase C modulators
UNIV LELAND STANFORD JUNIOR0 citations48
CELLGATE INC
6 patentsUS6669951B2Dec 30, 2003
Compositions and methods for enhancing drug delivery across and into epithelial tissues
CELLGATE INC148 citations98
US6593292B1Jul 15, 2003
Compositions and methods for enhancing drug delivery across and into epithelial tissues
CELLGATE INC163 citations98
US6730293B1May 4, 2004
Compositions and methods for treating inflammatory diseases of the skin
CELLGATE INC83 citations97
US7229961B2Jun 12, 2007
Compositions and methods for enhancing drug delivery across and into ocular tissues
CELLGATE INC55 citations95
US7169814B2Jan 30, 2007
Guanidinium transport reagents and conjugates
CELLGATE INC76 citations95
US6759387B2Jul 6, 2004
Compositions and methods for enhancing drug delivery across and into epithelial tissues
CELLGATE INC67 citations95
WENDER PAUL A
5 patentsUS8497385B2Jul 30, 2013
Bryostatin analogues, synthetic methods and uses
WENDER PAUL A12 citations83
US8816122B2Aug 26, 2014
Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use
WENDER PAUL A10 citations74
US8067632B2Nov 29, 2011
Process to produce prostratin and structural or functional analogs thereof
WENDER PAUL A5 citations60
US8536378B2Sep 17, 2013
Prostratin and structural or functional analogs thereof
WENDER PAUL A4 citations58
US8653238B2Feb 18, 2014
Compositions and methods for transport of molecules with enhanced release properties across biological barriers
WENDER PAUL A1 citations44
ROTHBARD JONATHAN B
3 patentsUS8623833B2Jan 7, 2014
Compositions and methods for enhancing drug delivery across and into epithelial tissues
ROTHBARD JONATHAN B18 citations91
US8729010B2May 20, 2014
Compositions and methods for enhancing drug delivery across and into ocular tissues
ROTHBARD JONATHAN B5 citations83
US8278264B2Oct 2, 2012
Compositions and methods for enhancing drug delivery across and into ocular tissues
ROTHBARD JONATHAN B7 citations83